Hyperlipidemia
418
23
28
298
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
72 trials with published results (17%)
Research Maturity
298 completed trials (71% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
3.6%
15 terminated out of 418 trials
95.2%
+8.6% vs benchmark
27%
114 trials in Phase 3/4
24%
72 of 298 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 298 completed trials
Clinical Trials (418)
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subjects
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)
Effects of Use of a Connected Pillbox On Medication Adherence
Development and Clinical Validation of Key Technologies for Non-invasive Breath Metabolic Fingerprinting for Large-scale Population Lipid Screening
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study
Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
Preventative Screening and Health Coaching in a Food Insecure Population
A Study to Evaluate COR-1004 in Adult Volunteers.
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants
Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT